Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

NCT01652729 ·Status: COMPLETED ·Phase: PHASE3

Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction

NCT00627744 ·Status: COMPLETED ·Phase: PHASE4

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

NCT00813228 ·Status: COMPLETED ·Phase: PHASE1

Sitagliptin Dose Determination Study

NCT01530178 ·Status: COMPLETED ·Phase: PHASE4

Safety Evaluation of Adverse Reactions in Diabetes

NCT02092597 ·Status: COMPLETED ·Phase: PHASE4

Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus

NCT00425490 ·Status: COMPLETED ·Phase: PHASE3

A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)

NCT01034111 ·Status: COMPLETED ·Phase: PHASE3

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

NCT02512523 ·Status: COMPLETED ·Phase: PHASE4

Januvia Re-examination Study (MK-0431-181)

NCT01062048 ·Status: COMPLETED

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

NCT01845831 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)

NCT01357135 ·Status: COMPLETED

Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus

NCT03829891 ·Status: COMPLETED ·Phase: NA

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

NCT00673894 ·Status: COMPLETED ·Phase: NA

The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients

NCT00716092 ·Status: COMPLETED ·Phase: PHASE2

Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes

NCT05303857 ·Status: COMPLETED ·Phase: PHASE4

Glucagon-like Peptide (GLP) Utilization and Safety

NCT01767389 ·Status: COMPLETED

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

NCT01937598 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation

NCT01552694 ·Status: COMPLETED ·Phase: PHASE3

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

NCT00551590 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Diabetes After Gastric Bypass With Sitagliptin

NCT01512797 ·Status: COMPLETED ·Phase: NA

Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations

NCT00334711 ·Status: COMPLETED ·Phase: NA

Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

NCT02636192 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

NCT02025907 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)

NCT00832390 ·Status: COMPLETED ·Phase: PHASE4

Effects of Saxagliptin on Endothelial Function

NCT01319357 ·Status: COMPLETED ·Phase: PHASE3